INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo MAYOGEL SUSPENSION

SCHEDULING STATUS:
Not Scheduled

PROPRIETARY NAME
(and dosage form):

MAYOGEL SUSPENSION

COMPOSITION:
Each 15 mL contains:

Aluminium hydroxide gel dried equivalent to
Aluminium oxide         282,00 mg
Magnesium trisilicate equivalent to
Magnesium oxide         120,00 mg
Alcohol 3,10% v/v
Preservatives: 
Methylparaben 0,20% m/v
Propylparaben 0,02% m/v

PHARMACOLOGICAL CLASSIFICATION:
Category A11.4.1 Antacids - Acid neutralisers.

PHARMACOLOGICAL ACTION:
Antacid, with the capability to neutralise the acid in the stomach.

INDICATIONS:
For the relief of gastric acidity, dyspepsia and peptic ulcers.

CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients. In patients with impaired renal function. The safety of this medicine in pregnant women has not yet been established.

WARNINGS:
Do not take this product if you are presently taking a prescription antibiotic product containing any form of tetracycline. Do not use this product if you have kidney disease except under the advice and supervision of a doctor.

DOSAGE AND DIRECTIONS FOR USE:
Adults only.
Two to three medicine measures one to three hours after meals and at bedtime; according to the need of the patient.
Do not use the maximum daily dosage of this product for more than two weeks. except under the advice and supervision of a doctor.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Aluminium hydroxide may cause nausea, vomiting, and constipation. Large doses may cause intestinal obstruction. Excessive doses, or even normal doses in patients with low-phosphate diets, may lead to phosphate depletion accompanied by increased resorption and urinary excretion of calcium with the risk of osteomalacia. Osteomalacia, and also encephalopathy and dementia can occur in patients with chronic renal failure who receive relatively high doses of aluminium hydroxide as a phosphate-binding agent. Magnesium trisilicate may cause diarrhoea. If renal function is impaired hypermagnesaemia may result. The symptoms of which include flushing of the skin, thirst, hypotension due to peripheral vasodilation, drowsiness, confusion, loss of tendon reflexes due to neuromuscular blockade, muscle weakness, respiratory depression, cardiac arrhythmias, coma, and cardiac arrest.
Aluminium hydroxide and magnesium trisilicate may interfere with the absorption of other drugs when these are taken concomitantly.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Refer to 'Side-Effects and Special Precautions' above.
Treatment is symptomatic and supportive.

IDENTIFICATION:
White suspension with odour of peppermint.

PRESENTATION:
100 mL, 200 mL, 350 mL, 500 mL, and 2,5 L in bottles.

STORAGE INSTRUCTIONS:
Store in a cool place below 25°C in airtight containers.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
E/11.4.1/1732

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Adcock Ingram Limited
Adcock Ingram Park
Harrisonlaan 17
Bryanston
Privaatsak X69, Bryanston, 2021

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
04/04/1974

New addition to this site: April 2004
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004